CompChem-Database: compound details

CompChem-Database: details for selected entry

DB01961 (2203)

Formula C₉H₁₄N₃O₈P

MW 323.2

InChIKey UOOOPKANIPLQPU-GJHYXATPNA-N

Entry_Date 2023-09-01

Net_Charge 0

Number_Atoms 35

Number_Heavy_Atoms 21

Number_Rings 2

Number_Bonds 36

Rotat_Bonds 8

Unbranched_Chain 2

Chiral_Centers 4

ONatoms 11

HB_Donor 5

HB_Acceptor 6

OpenEye_HB_Donors 6

OpenEye_HB_Acceptors 6

Lipinski_HB_Donors 5

Lipinski_HB_Acceptors 11

Lipinski_Violations 1

XLogP3 0

XLogP -3.24

logP -1.8648

PSA 187.17

MR 66.7581

ABS 0.55

Solubility highly

Aggregator Pass

PM7_Heat_of_Formation_kcal_per_mol -368.68532

PM7_Total_Energy_ev -4393.67212

PM7_Electronic_Energy_ev -28970.48804

PM7_Dipole_Debye 6.03979

PM7_Point_Group C1

PM7_HOMO_Energy_ev -9.719

PM7_LUMO_Energy_ev -0.589

PM7_COSMO_Area_square_ang 291.08

PM7_COSMO_Volue_cubic_ang 325.05

PM7_Electron_Affinity_ev 0.589

PM7_Ionization_Energy_ev 9.719

PM7_Energy_Gap_ev 9.13

PM7_Global_Hardness_ev 4.565

PM7_Global_Softness_ev 0.21905805038335158

PM7_Chemical_Potential_ev -5.154

PM7_Electronigativity_ev 5.154

PM7_Back_Donation_Energy_ev -1.14125

PM7_Electrophilicity_ev 2.9094979189485213

OPENEYE_Name [(2~{R},3~{S},4~{R},5~{R})-5-(4-amino-2-oxo-pyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] dihydrogen phosphate

SMILES c1cn(c(=O)nc1N)C2C(C(C(O2)CO)OP(=O)(O)O)O

Canonical_SMILES OC[C@H]1O[C@H]([C@@H]([C@@H]1OP(=O)(O)O)O)n1ccc(nc1=O)N

InChI 1/C9H14N3O8P/c10-5-1-2-12(9(15)11-5)8-6(14)7(4(3-13)19-8)20-21(16,17)18/h1-2,4,6-8,13-14H,3H2,(H2,10,11,15)(H2,16,17,18)/f/h16-17H,10H2

InChI_3D 1S/C9H14N3O8P/c10-5-1-2-12(9(15)11-5)8-6(14)7(4(3-13)19-8)20-21(16,17)18/h1-2,4,6-8,13-14H,3H2,(H2,10,11,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1

AuxInfo 1/1/N:1,2,9,7,3,6,5,8,4,12,10,11,17,16,13,14,18,19,15,20,21/E:(16,17,18)/F:1,2,9,7,3,6,5,8,4,12,10,11,17,16,13,18,19,14,15,20,21/E:(16,17)/rA:35cCCCCCCCCCNNNOOOOOOOOPHHHHHHHHHHHHHH/rB:d1;s1;;;s5;s5;s6;s7;d3s4;s2s4s8;s3;d4;;s7s8;s6;s9;;;s5;d14s18s19s20;s1;s2;s5;s6;s7;s8;s9;s9;s12;s12;s16;s17;s18;s19;/rC:;0,1.0051,0;.8674,-.4976,0;1.7348,1.0051,0;.2075,3.9942,0;1.0743,3.4926,0;-.5345,3.324,0;.8674,2.5126,0;-2.0522,2.4528,0;1.7348,0,0;.8674,1.5126,0;.8674,-1.4976,0;2.6023,1.5026,0;2.4123,7.0276,0;-.1318,2.4083,0;2.739,2.9527,0;-2.9195,1.9549,0;1.0155,6.8067,0;2.6333,5.6308,0;1.2364,5.4098,0;1.8244,6.2187,0;-.4327,-.2506,0;-.4337,1.2538,0;-.1643,4.3285,0;1.2778,3.9493,0;-.8282,3.7286,0;1.3647,2.4607,0;-2.3012,2.8864,0;-1.8033,2.0191,0;.4344,-1.7476,0;1.3004,-1.7476,0;3.1103,3.2875,0;-3.3519,2.206,0;1.0678,7.3039,0;2.5809,5.1335,0;

Duplicates DB01961

mol2_Path /CCDB/DrugBank/Database/Compound-0000000000-0000049999/Compound-0000001750-0000001999/DB01961.mol2

pdbqt_Path /CCDB/DrugBank/Database/Compound-0000000000-0000049999/Compound-0000001750-0000001999/DB01961.pdbqt

sdf_Path /CCDB/DrugBank/Database/Compound-0000000000-0000049999/Compound-0000001750-0000001999/DB01961.sdf

Formula	C₉H₁₄N₃O₈P
MW	323.2
InChIKey	UOOOPKANIPLQPU-GJHYXATPNA-N
Entry_Date	2023-09-01
Net_Charge	0
Number_Atoms	35
Number_Heavy_Atoms	21
Number_Rings	2
Number_Bonds	36
Rotat_Bonds	8
Unbranched_Chain	2
Chiral_Centers	4
ONatoms	11
HB_Donor	5
HB_Acceptor	6
OpenEye_HB_Donors	6
OpenEye_HB_Acceptors	6
Lipinski_HB_Donors	5
Lipinski_HB_Acceptors	11
Lipinski_Violations	1
XLogP3	0
XLogP	-3.24
logP	-1.8648
PSA	187.17
MR	66.7581
ABS	0.55
Solubility	highly
Aggregator	Pass
PM7_Heat_of_Formation_kcal_per_mol	-368.68532
PM7_Total_Energy_ev	-4393.67212
PM7_Electronic_Energy_ev	-28970.48804
PM7_Dipole_Debye	6.03979
PM7_Point_Group	C1
PM7_HOMO_Energy_ev	-9.719
PM7_LUMO_Energy_ev	-0.589
PM7_COSMO_Area_square_ang	291.08
PM7_COSMO_Volue_cubic_ang	325.05
PM7_Electron_Affinity_ev	0.589
PM7_Ionization_Energy_ev	9.719
PM7_Energy_Gap_ev	9.13
PM7_Global_Hardness_ev	4.565
PM7_Global_Softness_ev	0.21905805038335158
PM7_Chemical_Potential_ev	-5.154
PM7_Electronigativity_ev	5.154
PM7_Back_Donation_Energy_ev	-1.14125
PM7_Electrophilicity_ev	2.9094979189485213
OPENEYE_Name	[(2~{R},3~{S},4~{R},5~{R})-5-(4-amino-2-oxo-pyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl] dihydrogen phosphate
SMILES	c1cn(c(=O)nc1N)C2C(C(C(O2)CO)OP(=O)(O)O)O
Canonical_SMILES	OC[C@H]1O[C@H]([C@@H]([C@@H]1OP(=O)(O)O)O)n1ccc(nc1=O)N
InChI	1/C9H14N3O8P/c10-5-1-2-12(9(15)11-5)8-6(14)7(4(3-13)19-8)20-21(16,17)18/h1-2,4,6-8,13-14H,3H2,(H2,10,11,15)(H2,16,17,18)/f/h16-17H,10H2
InChI_3D	1S/C9H14N3O8P/c10-5-1-2-12(9(15)11-5)8-6(14)7(4(3-13)19-8)20-21(16,17)18/h1-2,4,6-8,13-14H,3H2,(H2,10,11,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1
AuxInfo	1/1/N:1,2,9,7,3,6,5,8,4,12,10,11,17,16,13,14,18,19,15,20,21/E:(16,17,18)/F:1,2,9,7,3,6,5,8,4,12,10,11,17,16,13,18,19,14,15,20,21/E:(16,17)/rA:35cCCCCCCCCCNNNOOOOOOOOPHHHHHHHHHHHHHH/rB:d1;s1;;;s5;s5;s6;s7;d3s4;s2s4s8;s3;d4;;s7s8;s6;s9;;;s5;d14s18s19s20;s1;s2;s5;s6;s7;s8;s9;s9;s12;s12;s16;s17;s18;s19;/rC:;0,1.0051,0;.8674,-.4976,0;1.7348,1.0051,0;.2075,3.9942,0;1.0743,3.4926,0;-.5345,3.324,0;.8674,2.5126,0;-2.0522,2.4528,0;1.7348,0,0;.8674,1.5126,0;.8674,-1.4976,0;2.6023,1.5026,0;2.4123,7.0276,0;-.1318,2.4083,0;2.739,2.9527,0;-2.9195,1.9549,0;1.0155,6.8067,0;2.6333,5.6308,0;1.2364,5.4098,0;1.8244,6.2187,0;-.4327,-.2506,0;-.4337,1.2538,0;-.1643,4.3285,0;1.2778,3.9493,0;-.8282,3.7286,0;1.3647,2.4607,0;-2.3012,2.8864,0;-1.8033,2.0191,0;.4344,-1.7476,0;1.3004,-1.7476,0;3.1103,3.2875,0;-3.3519,2.206,0;1.0678,7.3039,0;2.5809,5.1335,0;
Duplicates	DB01961
mol2_Path	/CCDB/DrugBank/Database/Compound-0000000000-0000049999/Compound-0000001750-0000001999/DB01961.mol2
pdbqt_Path	/CCDB/DrugBank/Database/Compound-0000000000-0000049999/Compound-0000001750-0000001999/DB01961.pdbqt
sdf_Path	/CCDB/DrugBank/Database/Compound-0000000000-0000049999/Compound-0000001750-0000001999/DB01961.sdf